FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366464123> ?p ?o ?g. }

• W4366464123 endingPage "423" @default.
• W4366464123 startingPage "415" @default.
• W4366464123 abstract "Patients with unresectable and metastasized gastrointestinal stromal tumor (GIST) experienced a remarkable improvement of progression-free survival (PFS) and overall survival (OS) after the introduction of imatinib. Our hypothesis is that the outcomes of treatment with imatinib are even better nowadays compared with the registration trials that were performed two decades ago. To study this, we used real-life data from a contemporary registry.A multicenter, retrospective study was performed by exploring clinical data from a prospective real-life clinical database, the Dutch GIST Registry (DGR). Patients with advanced GIST treated with first-line imatinib were included and PFS (primary outcome) and OS (secondary outcome) were analyzed. Results of our study were compared with published results of the European Organisation for Research and Treatment of Cancer (EORTC) 62005 trial, which marked the first era of imatinib in the treatment of GIST.Overall, 420 of the 435 patients treated with imatinib in the DGR had recorded response evaluation and were included in the analysis. During a median follow-up of 35.0 months (range 2.0-136.0), progression of GIST was eventually observed in 217 patients (51.2%). The DGR cohort showed a longer median PFS (33.0 months, 95% confidence interval [CI] 28.4-37.6) compared with the EORTC 62005 trial (an estimated PFS of 19.5 months). Additionally, the median OS of 68.0 months (95% CI 56.1-80.0) was longer than the exposed median OS (46.8 months) published in the long-term follow-up results of the EORTC 62005 trial (median follow-up duration 10.9 years).This study provides an update on outcomes of imatinib in the treatment of advanced GIST patients and demonstrates improved clinical outcomes since the first randomized studies of imatinib 2 decades ago. Furthermore, these results represent outcomes in real-world clinical practice and can serve as a reference when evaluating effectiveness of imatinib in patients with advanced GIST." @default.
• W4366464123 created "2023-04-22" @default.
• W4366464123 creator A5021911321 @default.
• W4366464123 creator A5037532883 @default.
• W4366464123 creator A5046503436 @default.
• W4366464123 creator A5047066048 @default.
• W4366464123 creator A5051744290 @default.
• W4366464123 creator A5066058445 @default.
• W4366464123 creator A5071462352 @default.
• W4366464123 creator A5076740454 @default.
• W4366464123 creator A5084671376 @default.
• W4366464123 date "2023-04-20" @default.
• W4366464123 modified "2023-10-01" @default.
• W4366464123 title "Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data" @default.
• W4366464123 cites W1981491302 @default.
• W4366464123 cites W2037290765 @default.
• W4366464123 cites W2059864409 @default.
• W4366464123 cites W2115504770 @default.
• W4366464123 cites W2116922255 @default.
• W4366464123 cites W2129931005 @default.
• W4366464123 cites W2139511378 @default.
• W4366464123 cites W2145131634 @default.
• W4366464123 cites W2169363650 @default.
• W4366464123 cites W2314511842 @default.
• W4366464123 cites W2373606074 @default.
• W4366464123 cites W2601222128 @default.
• W4366464123 cites W2653632515 @default.
• W4366464123 cites W2782077264 @default.
• W4366464123 cites W2805725835 @default.
• W4366464123 cites W3014683777 @default.
• W4366464123 cites W3190432210 @default.
• W4366464123 cites W4200569669 @default.
• W4366464123 cites W4206922330 @default.
• W4366464123 doi "https://doi.org/10.1007/s11523-023-00960-y" @default.
• W4366464123 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37079223" @default.
• W4366464123 hasPublicationYear "2023" @default.
• W4366464123 type Work @default.
• W4366464123 citedByCount "0" @default.
• W4366464123 crossrefType "journal-article" @default.
• W4366464123 hasAuthorship W4366464123A5021911321 @default.
• W4366464123 hasAuthorship W4366464123A5037532883 @default.
• W4366464123 hasAuthorship W4366464123A5046503436 @default.
• W4366464123 hasAuthorship W4366464123A5047066048 @default.
• W4366464123 hasAuthorship W4366464123A5051744290 @default.
• W4366464123 hasAuthorship W4366464123A5066058445 @default.
• W4366464123 hasAuthorship W4366464123A5071462352 @default.
• W4366464123 hasAuthorship W4366464123A5076740454 @default.
• W4366464123 hasAuthorship W4366464123A5084671376 @default.
• W4366464123 hasBestOaLocation W43664641231 @default.
• W4366464123 hasConcept C126322002 @default.
• W4366464123 hasConcept C141071460 @default.
• W4366464123 hasConcept C143998085 @default.
• W4366464123 hasConcept C167135981 @default.
• W4366464123 hasConcept C16930146 @default.
• W4366464123 hasConcept C2775922572 @default.
• W4366464123 hasConcept C2777007597 @default.
• W4366464123 hasConcept C2777583451 @default.
• W4366464123 hasConcept C2778729363 @default.
• W4366464123 hasConcept C3019892230 @default.
• W4366464123 hasConcept C44249647 @default.
• W4366464123 hasConcept C535046627 @default.
• W4366464123 hasConcept C71924100 @default.
• W4366464123 hasConcept C72563966 @default.
• W4366464123 hasConceptScore W4366464123C126322002 @default.
• W4366464123 hasConceptScore W4366464123C141071460 @default.
• W4366464123 hasConceptScore W4366464123C143998085 @default.
• W4366464123 hasConceptScore W4366464123C167135981 @default.
• W4366464123 hasConceptScore W4366464123C16930146 @default.
• W4366464123 hasConceptScore W4366464123C2775922572 @default.
• W4366464123 hasConceptScore W4366464123C2777007597 @default.
• W4366464123 hasConceptScore W4366464123C2777583451 @default.
• W4366464123 hasConceptScore W4366464123C2778729363 @default.
• W4366464123 hasConceptScore W4366464123C3019892230 @default.
• W4366464123 hasConceptScore W4366464123C44249647 @default.
• W4366464123 hasConceptScore W4366464123C535046627 @default.
• W4366464123 hasConceptScore W4366464123C71924100 @default.
• W4366464123 hasConceptScore W4366464123C72563966 @default.
• W4366464123 hasFunder F4320307771 @default.
• W4366464123 hasFunder F4320307778 @default.
• W4366464123 hasFunder F4320316900 @default.
• W4366464123 hasFunder F4320333645 @default.
• W4366464123 hasIssue "3" @default.
• W4366464123 hasLocation W43664641231 @default.
• W4366464123 hasLocation W43664641232 @default.
• W4366464123 hasLocation W43664641233 @default.
• W4366464123 hasLocation W43664641234 @default.
• W4366464123 hasLocation W43664641235 @default.
• W4366464123 hasLocation W43664641236 @default.
• W4366464123 hasLocation W43664641237 @default.
• W4366464123 hasOpenAccess W4366464123 @default.
• W4366464123 hasPrimaryLocation W43664641231 @default.
• W4366464123 hasRelatedWork W1964805506 @default.
• W4366464123 hasRelatedWork W2067326946 @default.
• W4366464123 hasRelatedWork W2069720810 @default.
• W4366464123 hasRelatedWork W2072506147 @default.
• W4366464123 hasRelatedWork W2075104739 @default.
• W4366464123 hasRelatedWork W2098166842 @default.
• W4366464123 hasRelatedWork W2114406679 @default.

• next